One of the most important factors leading to the rising demand for aspiration and biopsy needles is the increasing prevalence of cancer across the world. According to the World Health Organization (WHO), the number of people who died from cancer stood at 9.6 million in 2018. Furthermore, the number of people suffering from malignant tumors will increase from 12.7 million in 2008 to 21.4 million in 2030, which will considerably boost the demand for aspiration and biopsy needles, on account of the fact that biopsy and aspiration procedures are extensively used for studying the nature of tumors.
The other major factors contributing to the surge in the demand for aspiration and biopsy needles are the rising popularity of minimally invasive surgeries, soaring healthcare expenditure in several countries, and rapid technological innovations in the devices used for disease diagnosis. Due to these factors, the global aspiration and biopsy needles market size is predicted to increase from $801.5 million in 2019 to $1,717.9 million in 2030. The market is expected to progress at a CAGR of 7.2% during the forecast period (2020–2030). |
| To Learn more about this report: https://bit.ly/31eyNAu |
The
biggest rage presently being witnessed in the aspiration and biopsy needles
market is the rising approvals for aspiration and biopsy needles. For
instance, the EZ Shot 3 Plus 25 G EUS, which is a single-use needle developed
by Olympus Corporation for fine-needle biopsy and aspiration procedures,
received approval from the U.S. Food and Drug Administration (USFDA) in
September 2018. This needle can be used to analyze and study the extramural and
submucosal lesions found in different sections of the
gastrointestinal tract.
Therefore,
owing to the rising incidence of cancer, increasing healthcare expenditure, and
surging awareness amongst the people throughout the world about the various
cancer diagnosis processes, the demand for aspiration and biopsy needles will
observe significant growth in future.
No comments:
Post a Comment